ACADIA Pharmaceuticals (LTS:0A4W) Float Percentage Of Total Shares Outstanding: 63.05% (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0A4W ACADIA Pharmaceuticals Inc LTS:0A4W
76 GF Score
Price $26.87
GF Value $26.51
! 9 Warning Signs
View Full Analysis

What is ACADIA Pharmaceuticals Float Percentage Of Total Shares Outstanding?

ACADIA Pharmaceuticals LTS:0A4W 76 Float Percentage Of Total Shares Outstanding is 63.05% as of Jul. 18, 2026. GuruFocus rates LTS:0A4W with a GF Score™ of 76/100 and a GF Value™ of $26.51. The stock has 9 warning signs investors should review.

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ACADIA Pharmaceuticals's float shares is 107.96 Mil. ACADIA Pharmaceuticals's total shares outstanding is 171.24 Mil. ACADIA Pharmaceuticals's float percentage of total shares outstanding is 63.05%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ACADIA Pharmaceuticals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ACADIA Pharmaceuticals's Institutional Ownership is 44.39%.

LTS:0A4W
76GF Score
ACADIA Pharmaceuticals Inc LTS:0A4W
Float Percentage Of Total Shares Outstanding is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ACADIA Pharmaceuticals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

ACADIA Pharmaceuticals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=107.96/171.24
=63.05%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Float Percentage Of Total Shares Outstanding of 63.05% mean?
ACADIA Pharmaceuticals (LTS:0A4W) has a Float Percentage Of Total Shares Outstanding of 63.05% as of Jul. 18, 2026. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on ACADIA Pharmaceuticals and its competitors.
Is ACADIA Pharmaceuticals' Float Percentage Of Total Shares Outstanding too high?
ACADIA Pharmaceuticals' current Float Percentage Of Total Shares Outstanding is 63.05%. Overall, ACADIA Pharmaceuticals has a GF Score™ of 76/100, reflecting its overall financial health beyond just this single metric.
How does ACADIA Pharmaceuticals' Float Percentage Of Total Shares Outstanding compare to VKTX and EWTX?
ACADIA Pharmaceuticals' Float Percentage Of Total Shares Outstanding of 63.05% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Float Percentage Of Total Shares Outstanding for a Biotechnology company?
A good Float Percentage Of Total Shares Outstanding depends on the Biotechnology industry context. However, Float Percentage Of Total Shares Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Float Percentage Of Total Shares Outstanding mean?
A high Float Percentage Of Total Shares Outstanding can signal that a stock is expensive relative to its fundamentals. Float percent of shares outstanding equals the percent of float shares relative to total shares. View historical data on ACADIA Pharmaceuticals and its competitors. ACADIA Pharmaceuticals's current Float Percentage Of Total Shares Outstanding is 63.05%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ACADIA Pharmaceuticals stock overvalued right now?
ACADIA Pharmaceuticals (LTS:0A4W) has a current Float Percentage Of Total Shares Outstanding of 63.05%. The stock's GF Value™ is $26.51, compared to a current price of $26.87 — trading 1.4% above its estimated fair value. The current Float Percentage Of Total Shares Outstanding is 63.05%. ACADIA Pharmaceuticals' overall GF Score™ is 76/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Float Percentage Of Total Shares Outstanding calculated?
Float Percentage Of Total Shares Outstanding is calculated from a company's financial statements. For ACADIA Pharmaceuticals (LTS:0A4W), the current Float Percentage Of Total Shares Outstanding is 63.05% as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is ACADIA Pharmaceuticals (LTS:0A4W) Overvalued in 2026?

Based on GuruFocus' analysis, ACADIA Pharmaceuticals stock appears to be overvalued. The current stock price of $26.87 is trading 1.4% above its estimated GF Value™ of $26.51.

Key valuation signals for LTS:0A4W:

  • Float Percentage Of Total Shares Outstanding: 63.05%
  • GF Value™: $26.51 vs. price of $26.87 (1.4% above fair value)
  • GF Score™: 76/100 with 9 warning signs

No single metric tells the full story. See the LTS:0A4W stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

ACADIA Pharmaceuticals Business Description

Address 12830 El Camino Real, Suite 400, San Diego, CA, USA, 92130
Acadia Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of medicines that address unmet medical needs in central nervous system (CNS) disorders and rare diseases. It has two core franchises in neuroscience and neuro-rare diseases. The neuroscience franchise is anchored by its commercial product NUPLAZID (pimavanserin), which is used for the treatment of hallucinations and delusions associated with Parkinson's Disease Psychosis (PDP). The neuro-rare disease franchise is anchored by the commercial product DAYBUE, which is used for the treatment of Rett syndrome. In addition, the company has various product candidates under development in different stages, including ACP-204, ACP-211, ACP-711, ACP-2591, etc.
76GF Score

Get the complete analysis for LTS:0A4W

Float Percentage Of Total Shares Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$26.87
Price
$26.51
GF Value